SCHEMBL20714552

SCHEMBL20714552

CCC/C(=N\NC=O)c1ccc(NC)c(C(F)(F)F)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 1/20 0.43
▸ ALDH1A1 P00352 4/20 0.34
▸ PDE3B Q13370 1/20 0.34
▸ PDE3A Q14432 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.32
▸ F2R P25116 1/20 0.32
▸ SMN1; SMN2 Q16637 3/20 0.32
▸ MAPT P10636 2/20 0.32
▸ AR P10275 1/20 0.32
▸ KMT2A Q03164 3/20 0.32
▸ RAB9A P51151 2/20 0.32
▸ CYP2D6 P10635 2/20 0.32
▸ CYP2C19 P33261 2/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ ALOX15 P16050 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ SLC9A1 P19634 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20714562 0.84 PDE3B (0.42) ALDH1A1PDE3BPDE3AKMT2AMEN1
SCHEMBL20714563 0.84 PDE3B (0.42) ALDH1A1PDE3BPDE3AKDM4EMAPT
SCHEMBL22317551 0.75 S1PR1 (0.41) ALDH1A1PDE3BPDE3AKDM4ESMN1; SMN2
SCHEMBL20716139 0.75 PDE3B (0.41) ALDH1A1PDE3BPDE3AKDM4EMAPT
SCHEMBL20714424 0.74 S1PR1 (0.37) SMN1; SMN2ARSLC9A1HPGD
SCHEMBL10283798 0.70 SMN1; SMN2 (0.56) ALDH1A1KDM4ESMN1; SMN2MAPTKMT2A
SCHEMBL20716460 0.70 NPFFR2 (0.42) ALDH1A1
SCHEMBL20716132 0.70 TAS1R3 (0.39) —
SCHEMBL21969831 0.69 SMN1; SMN2 (0.39) ALDH1A1KDM4ESMN1; SMN2MAPTKMT2A
SCHEMBL7166120 0.69 APP (0.54) APPALDH1A1PDE3BPDE3AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019025554-A1 6-PHENYL-4,5-DIHYDROPYRIDAZIN-3(2H)-ONE DERIVATIVES AS PDE3A AND PDE3B INHIBITORS FOR TREATING CANCER BAYER AKTIENGESELLSCHAFT (DE) 2019-02-07 — — WO disclosed
Send feedback